Skip to main content
lexblog.com/lib/2DQHGWBTviewrecordjson
LEX-WK-2DQHGWBTcrawled 2018-07-30 09:32Z

New Guidance Makes Clear that FDA Is Focused on Insanitary Conditions at Pharmacy Compounders

Robert Church · Jim Johnson · Christopher Fanelli · Focus on Regulation · Published August 3, 2016

Work details

firm or organization
Hogan Lovells
published
2016-08-03

Citation

Robert Church, Jim Johnson, Christopher Fanelli, New Guidance Makes Clear that FDA Is Focused on Insanitary Conditions at Pharmacy Compounders, Focus on Regulation (August 3, 2016) [The Library at LexBlog, LEX-WK-2DQHGWBT, lexpid.org/2DQHGWBT]